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Abstract
Norepinephrine (NE) produces multifaceted regulatory patterns in T-lymphocytes.
Recently, we have shown that NE utilizes redox signaling as evidenced by increased super-
oxide (O2
-) causally linked to the observed changes in these cells; however, the source of
this reactive oxygen species (ROS) remains elusive. Herein, we hypothesized that the
source of increased O2
- in NE-stimulated T-lymphocytes is due to disruption of mitochon-
drial bioenergetics. To address this hypothesis, we utilized purified mouse splenic CD4+
and CD8+ T-lymphocytes stimulated with NE and assessed O2
- levels, mitochondrial
metabolism, cellular proliferation, and cytokine profiles. We demonstrate that the increase
in O2
- levels in response to NE is time-dependent and occurs at later points of T-lympho-
cyte activation. Moreover, the source of O2
- was indeed the mitochondria as evidenced by
enhanced MitoSOX Red oxidation as well as abrogation of this signal by the addition of the
mitochondrial-targeted O2
--scavenging antioxidant MitoTempol. NE-stimulated T-lympho-
cytes also demonstrated decreased mitochondrial respiratory capacity, which suggests dis-
ruption of mitochondrial metabolism and the potential source of increased mitochondrial
O2
-. The effects of NE in regards to redox signaling appear to be adrenergic receptor-
dependent as specific receptor antagonists could reverse the increase in O2
-; however,
differential receptors regulating these processes were observed in CD4+ versus CD8+ T-
lymphocytes. Finally, mitochondrial O2
-was shown to be mechanistic to the NE-mediated
T-lymphocyte phenotype as supplementation of MitoTempol could reverse specific
changes in cytokine expression observed with NE treatment. Overall, these studies indicate
that mitochondrial metabolism and O2
--mediated redox signaling play a regulatory role in
the T-lymphocyte response to NE.
Introduction
Enhanced activation of the sympathetic nervous system is associated with numerous pathologi-
cal conditions ranging from hypertension, heart failure, diabetes, and even psychological stress
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[1–4]. Sympathoexcitation leads to increased norepinephrine (NE) outflow to peripheral
organs including the predominantly sympathetic-innervated lymphoid organs including the
bonemarrow, lymph nodes, and spleen[5]. Resident immune cells in these lymphoid organs
have been shown to possess adrenergic receptors[6, 7], and over the last four decades it has
becomewell-accepted that autonomic regulation of the immune system is a tangible phenome-
non[8, 9]. However, catecholamines appear to elicit a complex pattern of regulation on
immune cells dependent upon numerous variables including cell type, activation status, polari-
zation and differentiation, organ of residence, and many others[10, 11].
One immune cell type that has been extensively studied for its effects with NE is T-lympho-
cytes. Early in vitro work with T-lymphocytes demonstrated that NE slows the proliferation of
these cells and decreases the amount of pro-inflammatory cytokine production through an
inhibition of interleukin 2 (IL-2), and this observation has been validated by numerous labora-
tories utilizing various populations of T-lymphocytes[11–15]. Moreover, NE appears to pro-
duce this inhibitory effect primarily through a 2 adrenergic receptor-mediated mechanism
[14]. In contrast, several investigations have shown that NE may enhance the pro-inflamma-
tory state of T-lymphocytes particularly in regards to interferon gamma (IFN ) production or
in the ability to fight infection[16–18]. Additionally, other studies have identifiedNE-mediated
effects on T-lymphocytes that are initiated via adrenergic receptors other than just the 2 iso-
form[15, 19–21]. Taken together, the complexity and disparity of observations in regards to
NE-mediated effects on T-lymphocytes suggests the potential for multidimensional regulatory
mechanisms that are not yet fully understood.
In 2013, Fadel and colleagues observed that human peripheral bloodmononuclear cells pro-
duced increased reactive oxygen species (ROS), particularly superoxide (O2
-), in response to
NE, and further suggested this to be an 2-adrenergic receptor-mediated effect[19].We have
recently confirmed and extended these findings specifically in T-lymphocytes both in vivo and
in vitro in a mouse model of sympathoexcitation[22]. Our results additionally suggested this
increase in O2
- was causal to the NE-driven effects in the T-lymphocytes as O2
--scavenging
antioxidant supplementation was able to partially inhibit the NE-mediated T-lymphocyte phe-
notype[22]. To our knowledge, these findings were the first to report the potential for redox
signaling in the regulation of NE-mediated effects in T-lymphocytes.
In the work presented herein, we aimed to expand upon our previous observation and iden-
tify the source of O2
- in NE-stimulated T-lymphocytes. Due to our previous observations that
the O2
- produced in response to NE appeared to be time dependent, we hypothesized that NE
may be altering mitochondrial metabolism and in turn affectingmitochondrial-derivedO2
-
specifically. We and others have recently reported that metabolism and redox signaling play an
integral role in T-lymphocyte activation, polarization, and function[23–28], and here we dem-
onstrate that NE may affect these central processes adding to the complexity of catecholamin-
ergic regulation of T-lymphocytes.
Materials and Methods
Mice
C57BL/6 breeding pair mice were originally purchased from Envigo RMS (Indianapolis, IN).
All experiments were performed using progeny virginmale mice (Age 8–12 weeks, weight 20–
25 g) kept in group/social housing from time of weaning. Breeding colonies were established
and maintained for a minimum of 6 months within one housing room to eliminate shipping or
room change stressors[29, 30]. With the exception of biweekly cage changes by a single female
technician[31], mice were not handled until sacrifice for T-lymphocyte isolation. Mice were
given access to standard chow (Teklad LaboratoryDiet #7012, Envigo RMS, Indianapolis, IN)
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and water ad libitum. Mice were euthanized by pentobarbital overdose (150 mg/kg, Fatal Plus,
Vortech Pharmaceuticals, Dearborn,MI) administered intraperitoneally. All procedures were
reviewed and approved by the University of Nebraska Medical Center Institutional Animal
Care and Use Committee.
T-lymphocyte isolation
Spleens frommice were dissected and physically disrupted into single cell suspensions using
ground glass slides (Thermo Fisher Scientific #6684h61, Waltham, MA), and run through
70 μM nylon mesh filters (Thermo Fisher Scientific #352350, Waltham, MA) to remove large
tissue debris. Red blood cell lysis buffer (15.5 mMNH4Cl, 1 mMKHCO3, 10 μM EDTA) was
used to remove contaminating erythrocytes.After a second filtering through 70 μM nylon
mesh, CD4+ and CD8+ T-lymphocytes were isolated by negative selection using the EasySep™
Mouse CD4+ T-Cell Isolation Kit (StemCell Technologies #19852, Vancouver, BC) or CD8
+ T-Cell Isolation Kit (StemCell Technologies # 19853, Vancouver, BC), respectively. The
purity of the respective T-lymphocyte populations was assessed by flow cytometry at >95%.
Treatment regimens
For treatment during T-lymphocyte activation, T-lymphocytes were seeded on tissue culture
plates coated using 10 μg/mL anti-CD3 antibody (eBioscience clone 145-2C11, #16-0031-086,
San Diego, CA) and 1 μg/mL anti-CD28 antibody (eBioscience clone 37.51, #16-0281-85, San
Diego, CA) as this concentration has been validated by our laboratory previously to provide
sufficient stimulation for both CD4+ and CD8+ T-lymphocytes grown independently[22]. T-
lymphocytes were cultured using RPMIMedium 1640 without phenol red (Gibco #11835–030,
Grand Island, NY) supplemented with 10% fetal bovine serum (Atlanta Biologicals #S11150,
Lawrenceville,GA), 2 mM L-glutamine (Hyclone #SH30034.02, Waltham, MA), 10 mM
HEPES (Thermo Fisher Scientific #BP299, Waltham, MA), 1% Penicillin/Streptomycin (Gibco
#15140–122, Grand Island, NY), and 50 μM -mercaptoethanol (Sigma-Aldrich #M6250,
St. Louis, MO). Doses ranging from 0.1–100 μMNE (Sigma-Aldrich #A7256, St. Louis,MO),
prazosin (Sigma-Aldrich #P7791, St. Louis, MO), atipamezole (Sigma-Aldrich #A9611,
St. Louis, MO), metoprolol (Sigma-Aldrich #M5391, St. Louis,MO), ICI 118,511 (Sigma-
Aldrich #I127, St. Louis, MO), atomoxetine (Sigma-Aldrich #Y0001586, St. Louis,MO), or
vehicle (phosphate-buffered saline, PBS) were added at time of plating and replenished every
24 hours for the duration of the experiment to counteract degradation by endogenous T-lym-
phocytemonoamine oxidases[32]. A concentration of 1 μM was universally used for follow-up
analyses due to its optimal effects with minimal toxicity, as well as previous work utilizing this
established physiological dose[33–35]. At time of analysis, cells were harvested and counted
utilizing size exclusion for live cells on a BeckmanCoulter counter. Cell media was used for
cytokine analysis. For acute treatment, freshly isolated T-lymphocytes were treated with 1 μM
NE for 30 minutes prior to respective analysis.
Immunophenotyping
After culture, T-lymphocytes were counted and resuspended in pre-warmed fresh phenol red-
free culture media (see aforementioned media recipe). Cells were blocked using anti-CD16/
CD32 antibody (BD Biosciences clone 2.4G2, #553141, San Jose, CA) prior to staining. The fol-
lowing antibodies were used at 1:100 to identify naïve, effector, or memory lineages of T-lym-
phocytes: APC-CD44 (BD Biosciences clone IM7, # 561862, San Jose, CA) and BV421-CD62L
(BD Biosciences clone MEL-14, # 562910, San Jose, CA). Antibodies were added and incubated
for 30 min at 37°C, and then washed twice using pre-warmed fresh media. T-lymphocytes
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were immediately analyzed by flow cytometry on a LSRII flow cytometer (BectonDickinson,
Franklin Lakes, NJ) and quantified using FlowJo cytometric analysis software (Tree Star, Ash-
land, OR). Cell lineages were defined as follows: Naïve, CD62L+, CD44-; Effector/Effector
Memory, CD62L-, CD44+; CentralMemory, CD62L+, CD44+. Immunophenotyping was per-
formed in warmedmedia due to concurrent superoxide measurements (see below).
Superoxide measurement
Total cellular O2
- levels were quantified by flow cytometry utilizing dihydroethidium (DHE)
and mitochondrial-derived O2
- levels were measured using MitoSOX Red (DHE conjugated
to a mitochondrial localization tag)[22, 25]. T-lymphocytes were resuspended in phenol red-
free culture media (see aforementioned media recipe) with 10 μM DHE (VWR #101447–534,
Chicago, IL) or MitoSOX Red (Thermo Fisher Scientific #M36008, Waltham, MA) for 30 min
at 37°C. Cells were analyzed on a FACSCalibur or LSRII flow cytometers at 488 nm excitation
and 575 nm emission. Electron paramagnetic resonance (EPR) spectroscopywas also utilized
for detection of intracellular O2
- as previously described[36].Briefly, T-lymphocytes
were incubated for 30 minutes at 37°C with the cell-permeableO2
--sensitive spin probe
1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH, 200 μmol/L, Noxygen
Science Transfer and Diagnostics, Elzach, Germany) in a Krebs-HEPES buffer (pH 7.4) con-
taining (in mmol/L): 99 NaCl, 4.69 KCl, 2.5 CaCl2, 1.2 MgSO4, 25 NaHCO3, 1.03 KH2PO4, 5.6
D-glucose, 20 HEPES, and supplemented with the metal chelators DETC (5 μM) and deferoxa-
mine (25 μM). Cells were analyzed using a Bruker e-scan EPR spectrometer. The following
EPR settings were used: field sweep width, 60.0 gauss; microwave frequency, 9.75 kHz; micro-
wave power, 21.90 mW; modulation amplitude, 2.37 gauss; conversion time, 10.24 ms; time
constant, 40.96 ms. For inhibition of NADPH oxidases, 1 μM of the NADPH oxidase/flavopro-
tein inhibitor diphenyleneiodonium (DPI; Sigma-Aldrich #D2926, St. Louis, MO) was added
to cell cultures 1 hour prior to harvest and analysis. To scavenge total or mitochondrial-specific
O2
-, 1 μM of Tempol (Enzo Life Sciences #ALX-430-081, Farmingdale, NY) or MitoTempol
(Enzo Life Sciences #ALX-430-150, Farmingdale, NY) was added, respectively, at time of plat-
ing and replenished every 24 hours for the duration of the experiment.
Mitochondrial bioenergetics analysis
To measure T-lymphocyte mitochondrial bioenergetics, a Seahorse Bioscience XFp extracellu-
lar flux analyzer was used. This device utilizes specializedmicroplates to create a closed cham-
ber able measure real-time oxygen consumption by mitochondria in live cells exposed to
various stimuli throughmultiple designed injection ports. Optimal seeding density of T-lym-
phocytes was established at 200,000 cells per well and was utilized for all experiments. Addi-
tionally, mitochondrial agents (Seahorse Bioscience Cell Mito Stress Test Kit #103015–100,
Boston,MA) were pre-optimized at 1 μM oligomycin, 1 μM FCCP, and 10 μM rotenone/anti-
mycin A to elicit maximal effects on mitochondrial respiration. Microplates were pretreated
with 1 μg/cm2 Cell-Tak (Corning #354240, Corning,NY) to allow T-lymphocyte adhesion to
the chamber. For acute NE treatment, T-lymphocytes were freshly isolated, counted, and
immediately seeded on microplates in minimal DMEM (Seahorse Bioscience XF BaseMedium
#102353, Boston,MA) supplemented with 11 mMD-glucose and 2 mM L-glutamine. NE was
administered by way of Seahorse injection port and cells analyzed for 30 minutes prior to mito-
chondrial stress test. For treatment of NE in activated T-lymphocytes, T-lymphocytes were cul-
tured for 96 hours as previously described in the presence of 1 μMNE. Cells were harvested,
counted, and seeded on microplates in minimal DMEM supplemented with 11 mMD-glucose
and 2 mM L-glutamine. Mitochondrial stress test was performed immediately without any
Mitochondrial Superoxide, Norepinephrine, and T-Lymphocytes
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additional NE administration. Cells from one mouse (vehicle and NE treated) were run on a
single plate in technical replicates; biological replicate plates were run and data pooled for
analysis.
Cytokine analysis
Extracellular secreted cytokine analysis was performed on cell media from T-lymphocytes cul-
tured for 96 hours. Analysis was performed using the mouse Th1/Th2/Th17 cytometric bead
array (BD Biosciences #560485, San Jose, CA) as per manufacturer’s instructions. Briefly,
media was combined with antibody-coated fluorescent beads for 7 specific cytokines used to
profile various T-lymphocyte subtypes. Beads were analyzed on a LSRII flow cytometer for
quantification of specific cytokines.
Statistics
Data are presented as mean ± standard error of the mean (SEM). For two group comparison,
significancewas assessed using the paired Student’s t-test. For multiple group comparison, sig-
nificance was assessed using 2-way ANOVA followed by Bonferroni post-hoc analysis. Differ-
ences were considered significant at p<0.05.
Results
NE increases O2
- in both CD4+ and CD8+ T-lymphocytes
In our previous report, we demonstrated that NE elevates steady-state O2
- levels in unfractio-
nated T-lymphocytes isolated from a mouse model of sympathoexcitation[22]. To expand
upon this observation,we isolated and purified primarymurine CD4+ or CD8+ T-lympho-
cytes and cultured them separately in the presence of increasing amounts of NE for 96 hours.
First, both CD4+ and CD8+ T-lymphocytes demonstrated a dose-dependent decrease in cell
proliferation (identified previously as a defect in proliferation as opposed to increased apopto-
sis[22]) with increasing amounts of NE (Fig 1A, S1A Fig). Moreover, the decrease in prolifera-
tion was correlated with an increase in cellular O2
- levels as evidencedby increasedDHE
oxidation and EPR spectrumamplitude in both CD4+ and CD8+ T-lymphocytes primarily at
later time points of activation (Fig 1B and 1C, S1B Fig). Additionally, the observedwhole-pop-
ulation shift of DHE oxidation (S1B Fig) implies the increase in O2
- is a pan-T-lymphocyte
phenomenon and not specific to one specific subtype of differentiated cells. This interpretation
is further supported by data demonstrating that all NE-treated T-lymphocytes in different
stages of activation (i.e. naïve, central memory, and effector/effectormemory) have increases in
O2
- compared to control cells even though NE aberrantly affects the percentages of T-lym-
phocytes in these respective populations (S2 Fig). Last, a dose of 1 μMNE was utilized for the
remainder of the experiments as it was the lowest dose observed to decrease cellular prolifera-
tion and increase O2
- levels, as well as has been previously reported as a physiologically rele-
vant concentration[11, 34, 35, 37].
Mitochondria are the source of O2
- in NE-stimulated T-lymphocytes
Under certain conditions, NE is known to generate free radical species independent of a recep-
tor-mediated or cell-dependentmechanism[38–40]. To ensure the increase in DHE oxidation
observedwith NE-stimulated T-lymphocytes was not due to direct interaction of the NE with
DHE, we tested the ability of NE to oxidize DHE in a cell free environment. We found no evi-
dence that NE was directly increasing DHE oxidation (S3 Fig), which suggested a cell-depen-
dent mechanism of O2
- generation. The NADPH oxidase (NOX) enzymes are a predominant
Mitochondrial Superoxide, Norepinephrine, and T-Lymphocytes
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source of intracellular O2
- and are known to be involved in many redox signaling processes
[36, 41, 42]. To identify if NOX enzymes were a source of O2
- in NE-stimulated T-lympho-
cytes, we utilized the pan-NOX inhibitor DPI. While we observed the typical increase in O2
-
in both CD4+ and CD8+ T-lymphocytes activated in the presence of NE, DPI had no effect in
attenuating this response suggestingNOX enzymes are not a predominant source of O2
- with
NE-stimulation in T-lymphocytes (Fig 2A). Following this, we next examined if mitochondria
were producing O2
- in response to NE utilizing the mitochondrial targeted O2
- probe Mito-
SOX Red. Intriguingly, we observed significant increases in MitoSOX oxidation in response to
NE at later time points of T-lymphocyte activation (Fig 2B) that correlated with the previously
observedDHE results (Fig 1B). To further examine mitochondrial O2
-, we utilized the mito-
chondrial targeted O2
- scavenger MitoTempol. Culturing the cells in the presence of Mito-
Tempol, but not the non-mitochondrial targeted version Tempol, was able to completely
attenuate the NE-mediated increase in O2
- in both CD4+ and CD8+ T-lymphocytes (Fig 2C),
thus further implicating mitochondria as a primary source of NE-mediated O2
- in T-
lymphocytes.
Mitochondrial bioenergetics are altered by NE in T-lymphocytes
Within a mitochondrion, there are many potential sources of O2
- generation, but the primary
source is due to electron leak onto oxygen from the electron transport chain[43, 44]. Due to
this, we measuredmitochondrial respiration in NE-stimulated T-lymphocytes utilizing a
Seahorse Bioscience extracellular flux bioanalyzer. This technology allows for real-time
Fig 1. NE provokes inverse effects on T-lymphocyte growth and O2
- levels. T-lymphocytes were isolated, purified, and activated via CD3/
CD28 stimulation in the presence of 1 M NE.A. T-lymphocyte growth curves at various time points of ex vivo culture. N = 4. B. Quantification of DHE
oxidation in CD4+ and CD8+ T-lymphocytes at various time points post-activation. N = 4. C. Representative EPR spectra showing amplitude (Amp)
for T-lymphocytes stimulated in the presence or absence of 1 M NE for 96 hours. N = 3. *p 0.05 vs. 0 M NE by Student’s t-test at respective time
points.
doi:10.1371/journal.pone.0164609.g001
Mitochondrial Superoxide, Norepinephrine, and T-Lymphocytes
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measurements of mitochondrial metabolism via the measurement of oxygen consumption in
response to specificmitochondrial respiratory chain inhibitors[45]. When examining the
effects of an acute exposure (30 minutes) of NE to T-lymphocytes, no changes were observed
in baseline oxygen consumption or with any mitochondrial inhibitor (Fig 3A), which corre-
lated with the lack of any detectable ROS production at this time point as well (Figs 1B and
2B). In contrast, T-lymphocytes activated in the presence of NE for 96 hours demonstrated a
decreased respiratory capacity response to the uncoupling agent carbonilcyanidep-triflouro-
methoxyphenylhydrazone (FCCP; Fig 3B). Increased ROS production from the mitochondria
and decreases in respiratory capacity are often associated, and are additionally correlated with
a numerous pathologies suggesting a possible mechanism behind altered T-lymphocyte func-
tion in response to NE[46–49]. Moreover, NE does not appear to affect T-lymphocyte mito-
chondrial ATP levels as the addition of oligomycin demonstrated similar inhibition in both NE
and control treated cells (Fig 3B). Overall, these data further support the mitochondria as the
source of O2
- in NE-treated T-lymphocytes and suggest bioenergetic dysfunctionmay play a
role in the observedphenotype.
Fig 2. Mitochondrial O2
- is increased in T-lymphocytes treated with NE. T-lymphocytes were isolated, purified, and activated via CD3/CD28
stimulation in the presence of 1 M NE. A. Quantification of DHE oxidation in CD4+ and CD8+ T-lymphocytes 96 hours post-activation. Cells were
incubated with DPI 1 hour prior to and during the incubation with DHE. N = 3. *p 0.05 vs. vehicle with 0 MNE by 2-way ANOVA followed by
Bonferroni post-hoc analysis.B. Quantification of MitoSOX red oxidation in CD4+ and CD8+ T-lymphocytes at various time points post-activation.
N = 6. *p 0.05 vs. 0 M NE by Student’s t-test at respective time points. C. Quantification of DHE oxidation in CD4+ and CD8+ T-lymphocytes at 96
hours post-activation. 1 M Tempol (Temp) or MitoTempol (MT) were supplemented at time of plating and every 24 hours post-activation. N = 4.
*p 0.05 vs. vehicle with 0 MNE; †p 0.05 vs. vehicle with 1 M NE by 2-way ANOVA followed by Bonferroni post-hoc analysis.
doi:10.1371/journal.pone.0164609.g002
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NE-mediated redox signaling appears dependent upon adrenergic
receptors
We next attempted to understand the mechanism by which NE was causing increasedmito-
chondrial O2
- in T-lymphocytes. Aforementioned, NE is able to auto-oxidize to generate free
radicals independent of cell or enzyme dependent mechanisms[38–40].While we demon-
strated NE was not directly oxidizing DHE, we postulated that if NE was able to enter the cells
it could possibly directly generate O2
- intracellularly. However, NE is not cell permeable and
requires specific transporters to import the catecholamine across the cell membrane. T-lym-
phocytes have been shown to express various catecholamine transporters as well as generate
their own NE which is transported across the cell membrane and utilized in an autocrine fash-
ion[21, 32, 50–53]. Due to this, we utilized the NE transporter (NET) inhibitor atomoxetine to
see if the intracellular import of NE was leading to the increase in O2
- in T-lymphocytes. In
contrast to our hypothesis, the addition of atomoxetine alone increasedO2
- within T-lym-
phocytes, and moreover, produced an additive effect with the supplementation of NE (Fig 4).
Additionally, atomoxetine alone demonstrated a dose-dependent decrease in cell number and
in combination with NE enhanced the proliferative defect (S4 Fig). Taken together, these data
suggest NE transport is not the primarymechanism by which NEmediates intracellular O2
-
production. Furthermore, the inhibition of NE uptake into the cell appears to enhance the NE-
Fig 3. T-lymphocyte mitochondrial reserve respiratory capacity is decreased with NE. T-lymphocytes were
isolated and purified. Cells were either immediately analyzed in a Seahorse Bioscience XFp extracellular flux
analyzer with a 30-minute acute treatment of 1 M NE, or activated via CD3/CD28 stimulation in the presence of
1 M NE for 96 hours prior to analysis. A. Cumulative average data of oxygen consumption rate (OCR) measured
over-time with acute treatment of NE. N = 9. B. Cumulative average data of OCRmeasured over-time in
activated T-lymphocytes cultured in the presence of NE. N = 9. *p 0.05 vs. 0 M NE by Student’s t-test at
respective time points.
doi:10.1371/journal.pone.0164609.g003
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mediated alterations suggesting T-lymphocytes may normally utilize this mechanism to metab-
olize the catecholamine and limit its effects.
The observation that inhibition of NE transport increased T-lymphocyte O2
- levels sug-
gested that more NE was available to bind extracellular adrenergic receptors, which would
potentiate the catecholaminergic effects. To examine the contribution of the adrenergic recep-
tors to the production of NE-mediatedO2
-, we utilized receptor specific antagonists (i.e. 1,
prazosin; 2, atipamezole; 1, metoprolol; 2, ICI 118,511) and measured intracellular O2
-
levels in T-lymphocytes. While NE significantly increasedO2
- levels in both CD4+ and CD8
+ T-lymphocytes cultured for 96 hours, the specific antagonists demonstrated variable
responses in the respective cell types (Fig 5). CD4+ cells showed a significant reduction in NE-
driven O2
- only when treated with the 2 antagonist (alone or in combination with 1 antag-
onism). Interestingly, individual antagonism had no effect, but both 1 and 2 blockade
Fig 4. Inhibiting NE transport increases intracellular O2
- levels. T-lymphocytes were isolated, purified,
and activated via CD3/CD28 stimulation in the presence of NE and/or the norepinephrine transporter
inhibitor atomoxetine. Quantification of DHE oxidation in CD4+ (upper) and CD8+ (lower) T-lymphocytes 96
hours post-activation. N = 4. *p 0.05 vs. vehicle with 0 M NE; †p 0.05 vs. vehicle with 1 M NE by 2-way
ANOVA followed by Bonferroni post-hoc analysis.
doi:10.1371/journal.pone.0164609.g004
Mitochondrial Superoxide, Norepinephrine, and T-Lymphocytes
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together increased intracellular O2
- alone and further exacerbated the increase in O2
- when
in combination with NE. In contrast, CD8+ cells also showed a trending reduction in NE-
driven O2
- with every antagonist, but only when combinations were utilized (i.e. 1 and 2,
or 1 and 2) were the results statistically significant. These differential responses between
CD4+ and CD8+ cells were not observedwith cellular proliferation, as only -blockade in both
cell types demonstrated any significant rescue in cell growth (S5–S7 Figs). Overall, these data
Fig 5. NE-mediated changes in O2
- are mediated via various adrenergic receptors. T-lymphocytes
were isolated, purified, and cells were activated via CD3/CD28 stimulation in the presence of 1 M NE or the
respective antagonist for 96 hours prior to analysis. Quantification of DHE oxidation in CD4+ (upper) and
CD8+ (lower) T-lymphocytes activated in the presence of the treatments for 96 hours. N = 4. *p 0.05 vs.
vehicle with 0 M NE; †p 0.05 vs. vehicle with 1 M NE by 2-way ANOVA followed by Bonferroni post-hoc
analysis.
doi:10.1371/journal.pone.0164609.g005
Mitochondrial Superoxide, Norepinephrine, and T-Lymphocytes
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suggest that NE mediates intracellular O2
- production in T-lymphocytes most likely through
the binding and activation of specific adrenergic receptors dependent upon cell type, and more-
over, these redox signaling events appear to be discordant to the mechanism driving decreases
in T-lymphocyte proliferation.
NE alters T-lymphocyte cytokine profiles in part due to mitochondrial
O2
-
We and others have reported that NE is able to alter cytokine production in T-lymphocytes,
however, the specific responses appear to be dependent upon several factors including experi-
mental setup and activation status of the cells[15, 17, 22, 33]. We hypothesized that the changes
in cytokine productionmay be partiallymediated by the increase in mitochondrial O2
- pro-
duced by NE in T-lymphocytes. To address this, we performed cytokine arrays on media from
CD4+ or CD8+ T-lymphocytes cultured with NE in the presence or absence of O2
- scaveng-
ing antioxidants. In CD4+ cells, NE significantly reduced IL-2, IFN , tumor necrosis factor
(TNF ), and IL-10 levels, while increasing IL-17A (Fig 6). Interestingly, the addition of Mito-
Tempol was able to significantly restore IL-2, IFN , and IL-17A levels in these cells (Fig 6). In
CD8+ cells, NE significantly reduced the same four cytokines as CD4+ cells (i.e. IL-2, IFN ,
TNF , and IL-10), but also increased both IL-17A and IL-6 levels (Fig 7). In these cells, Mito-
Tempol was able to significantly reestablish IL-6, IL-17A, and IL-10 levels (Fig 7). Interestingly,
growth was not restored in either CD4+ or CD8+ T-lymphocytes treated with antioxidants
(Figs 6 and 7), which further supports differential regulation between growth and cytokine pro-
duction in regards to NE-mediated redox signaling. Taken together, these data further support
the hypothesis of differential redox regulation in CD4+ and CD8+ cells, but also suggest that
increasedmitochondrial O2
- signaling is only partially contributing to the NE-mediated regu-
lation of T-lymphocytes as not all cytokines or growth could be rescued with the attenuation of
the NE-mediatedmitochondrial redox signaling.
Discussion and Conclusion
Investigations into the crosstalk between the nervous and immune systems have been ongoing
for several decades. Previously, we observed a new paradigm of redox control in the regulation
of T-lymphocytes exposed to NE[22]. In the work presented herein, we have expanded this
original observation to identify that mitochondria (and possibly mitochondrial metabolic dys-
function) are the source of the increasedO2
- in response to NE.
In recent years, it has become appreciated that ROS are necessary for proper T-lymphocyte
activation and function. Initial studies identified that both O2
- and hydrogen peroxide
(H2O2) were produced upon crosslinking of the T-lymphocyte receptor, which stimulated the
ERK signaling pathway modulating T-lymphocyte activation[54]. Soon after this work, T-lym-
phocytes were identified to possess a distinctly unique NAPDH oxidase that was the source of
this ROS upon T-lymphocyte receptor stimulation[55]. Moreover, we and others have shown
that mitochondrial derived ROS are also critical in the development and function of T-lympho-
cytes[23, 25]. However, while ROS have demonstrated a critical functional role in T-lympho-
cytes, the actual redox signalingmechanisms involved in these processes remain elusive. In the
work presented here, we confirm the finding that mitochondrial O2
- is increasedwith T-lym-
phocyte activation over time and report for the first time that NE-stimulation is able to potenti-
ate this specific ROS production which can alter T-lymphocyte cytokine production. How NE
facilitates its effects on the mitochondria remains unclear, but we hypothesize the mediator
may be cyclic AMP (cAMP) or its derivatives. Early work examining NE effects on T-lympho-
cytes demonstrated the observedphenotype is highly attributed to a significant induction of
Mitochondrial Superoxide, Norepinephrine, and T-Lymphocytes
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cAMP via the classic G protein-coupled receptor pathway[5, 9]. Recently, it has been observed
that cAMP derivatives may affect mitochondrial ROS and metabolism via altering the mito-
chondrial permeability transition pore (MPTP)[56, 57]. This pathway may explain how NE is
able to exert its effects on the mitochondria in T-lymphocytes. Moreover, this mechanism
could explain why we observed increases in O2
- over time and not acutely, as a buildup of
cAMPmay be required to significantly alter MPTP function,mitochondrial polarization, and
ROS production. Overall, this hypothesis warrants further investigation, and is a focus of cur-
rent work in our laboratory.
In addition to ROS, cellular metabolism has become accepted as a primary regulator of T-
lymphocyte activation and differentiation.Work from Pearce and colleagues has identified that
T-lymphocytes shift their metabolic profiles dependent upon activation and differentiation sta-
tus[26–28, 58]. For example, naïve T-lymphocytes reside in a relatively quiescent state with
minimal metabolic needs, however, upon activation to effector T-lymphocytes these cells uti-
lize theWarburg Effect and heavily rely upon glycolysis over mitochondrial oxidative phos-
phorylation to fulfill their metabolic demand to proliferate and function[28]. In contrast,
memory T-lymphocytes significantly enhance their mitochondrial biomass and rely exclusively
Fig 6. Mitochondrial O2
- partially regulates CD4+ T-lymphocyte cytokine profiles.CD4+ T-lymphocytes were isolated, purified, and activated
via CD3/CD28 stimulation in the presence of NE, Tempol (1 M), and/or MitoTempol (1 M) for 96 hours. Media was harvested for cytokine analysis
and results normalized to cell number. N = 5. *p 0.05 vs. vehicle with 0 M NE; †p 0.05 vs. vehicle with 1 M NE by 2-way ANOVA followed by
Bonferroni post-hoc analysis.
doi:10.1371/journal.pone.0164609.g006
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on oxidative phosphorylation for their function, which is believed to provide a significant
advantage to rapidly respond to a secondary immune insult[59–63]. Mitochondrial respiratory
capacity is linked to T-lymphocyte memory cell development[61], and furthermore, others
have shown that NE does in fact affect memory T-lymphocyte function[34]. Our data pre-
sented herein indicates that NE significantly decreasesmitochondrial respiratory capacity, and
this mechanismmay explain the NE-mediated changes in memory T-lymphocyte function pre-
viously reported. However, it remains unclear at this time if the NE-mediatedmitochondrial
dysfunction leads to the increase in mitochondrial O2
- or vice versa.
Our data utilizingmitochondrial-targeted antioxidant supplementation demonstrate a par-
tial rescue of the NE-mediated changes in T-lymphocytes, however, the attenuation of O2
-
was not able to fully restore growth or all cytokine levels back to normal. These data suggest
that these processes are controlled, at least in part, by NE signaling through non-redox regu-
lated mechanisms (i.e. cAMP and PKA[9, 64], changes in cyclin expression[22], etc.) or that
alterations in mitochondrialmetabolismmay be upstream of the increasedO2
- production.
Thus, attenuating the ROS via O2
- scavenging restores the redox-regulated signaling pro-
cesses but does not eliminate the continued metabolic defect, which may be causal to other
Fig 7. Mitochondrial O2
- partially regulates CD8+ T-lymphocyte cytokine profiles.CD8+ T-lymphocytes were isolated, purified, and activated
via CD3/CD28 stimulation in the presence of NE, Tempol (1 M), and/or MitoTempol (1 M) for 96 hours. Media was harvested for cytokine analysis
and results normalized to cell number. N = 5. *p 0.05 vs. vehicle with 0 M NE; †p 0.05 vs. vehicle with 1 M NE by 2-way ANOVA followed by
Bonferroni post-hoc analysis.
doi:10.1371/journal.pone.0164609.g007
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aspects of NE-driven changes in T-lymphocytes. For example, metabolite alterations can
directly affect the production of specific T-lymphocyte cytokines through regulation of their
mRNA via post-transcriptionalmodifications[65].Understanding that NE appears to have
multifaceted regulation on various cellular processes including metabolism, it is intuitive that
the addition of an antioxidant would not be sufficient to reverse all NE-mediated processes in
the cells, but only those that are specifically controlled via redox mechanisms (Fig 8).
As part of the phenotype observed in this work, we identified significant changes to cytokine
profiles in T-lymphocytes treated with NE. First, we identified that IL-2, IFN , and TNF were
all significantly down-regulated in both CD4+ and CD8+ T-lymphocytes treated with NE; a
finding that we and others have reported previously[9, 15, 22, 64]. Additionally, we also
observed changes in IL-17A, IL-10, and IL-6. These cytokines are not always reportedly altered
in T-lymphocytes in response to NE, but we attribute these conflicting results to variances in
experimental setup (i.e. mouse strain, activation stimulus, time course, NE dosage and regimen,
etc.) as previously discussed[10, 11]. Interestingly, these three cytokines were all demonstrated
to be redox regulated, as antioxidant supplementation could reverse their aberrant expression.
Moreover, their pattern of expression (i.e. increased IL-17A and IL-6, decreased IL-10) suggests
a pro-inflammatory profile with increased abundance of TH17 polarization. TH17 cells
Fig 8. Proposed NE signaling cascade in T-lymphocytes. T-lymphocytes have been shown to express
all adrenergic receptors, and NE has binding affinity to each isoform. In both CD4+ and CD8+ cells, NE
appears to reduce proliferation via -receptor canonical signaling (solid arrows) independent of redox
events. CD4+ cells utilize the 2 receptor while CD8+ cells use all four adrenergic receptors to initiate redox
signaling (dashed arrows) to affect specific subsets of cytokines. In both cells, the addition of MitoTempol
can decrease this increase in mitochondrial O2
- and reverse the changes in specific cytokine expression.
doi:10.1371/journal.pone.0164609.g008
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primarily produce the pro-inflammatory cytokine IL-17A, and while specific cytokines are
known to augment the polarization of T-lymphocytes to this subtype, the intracellular mecha-
nisms controlling this differentiation have yet to be fully elucidated. To date, the major tran-
scription factors known to contribute to TH17 differentiation are the retinoic acid receptor-
related orphan receptor gamma (ROR ) and Janus kinase/signal transducer and activator of
transcription (JAK/STAT) pathways[66]. It may be possible that NE signaling via non-canoni-
cal (i.e. increasedmitochondrial O2
- or altered cellular metabolites) pathways activates these
pro-TH17 signaling pathways, thus leading to the redox-regulated increase in IL-17 in T-lym-
phocytes treated with NE, as reported herein. Interestingly, TH17 cells are often associated with
autoimmune diseases, and recent reports have demonstrated diseases of increased sympathetic
drive appear to be associated with higher abundance of autoimmune and TH17 T-lymphocytes
[67–69]. For example, patients suffering from post-traumatic stress disorder (PTSD) possess
increased incidence rates of the autoimmune disease rheumatoid arthritis[70, 71]. Because
PTSD is known to elevate sympathetic drive[72], and that rheumatoid arthritis is also known
to be affected by elevated levels of NE[73, 74], it suggests autonomic dysfunction as a possible
link between psychological and autoimmune diseases. To date, mitochondrial-targeted antioxi-
dant supplementation has not been examined as a potential treatment in these diseases, and as
such our data may support further investigation into the potential of this therapeutic modality.
This study does possess some limitations that will need to be addressed in future work.
First, we exclusively utilizedCD3/CD28 stimulation as the mechanism to activate T-lympho-
cytes.While this is an established immunologic procedure, this methodologyprecludes exami-
nation as to whether the redox effects we observed are also produced during antigen-specific
activation of T-lymphocytes in vitro as well as in vivo. These studies along with culturing the
T-lymphocytes in polarizing conditions (i.e. TH1, TH2, Treg) may provide additional informa-
tion as to how specific subtypes of T-lymphocytes utilize redox regulation in response to NE.
Furthermore, our studies were carried out ex vivo, in ambient (approximately 21%) oxygen
conditions, as well as in the presence of standard high glucosemedia. Follow-up studies will
use in vivomodels of sympathoexcitation as well as utilize gas controlled work stations to
mimic physiological concentrations of oxygen as well as varyingmetabolic substrates to gain a
deeper understanding of the metabolic and redox effects of NE on T-lymphocytes under differ-
ent physiological conditions. Lastly, examination of the adrenergic receptors responsible for
initiating NE-mediatedO2
- production depicted a complex pattern of regulation. In CD4
+ cells, the 2 receptor appeared to be primarily responsible for the NE-driven increase in
O2
-, and this result agrees with a previous report of O2
- production in human immune cells
[19]. However, in CD8+ cells the pattern of adrenergic receptor regulation was complex and
appeared to involve all receptors analyzed. It is unclear at this time why and how these patterns
are divergent, but may be due to differential receptor density, sensitivity, or evenmitochondrial
content and signaling[75] betweenCD4+ and CD8+ T-lymphocytes. Investigations into these
differences and their responses to adrenergic stimulation and blockade are highly warranted as
patients currently taking adrenergic inhibitors may be subject to altered immune regulation
[76] due to disproportionate binding of physiological NE concentrations to the remaining
available adrenergic receptors.
In conclusion, our results present the unique observation that NE modulates T-lymphocyte
function via alterations in mitochondrial metabolism and redox status, primarily through the
generation of mitochondrial O2
-. The interplay of the nervous and immune systems is incred-
ibly complex, and this study illuminates a single possible mechanism of regulation. It remains
unclear how other neurotransmitters such as epinephrine, acetylcholine, neuropeptide Y, or
substance P affect T-lymphocyte redox signaling.Moreover, the understanding of how these
compounds affect the oxidative status of other components of the immune system (i.e. B-
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lymphocytes, macrophages, dendritic cells, etc.) remains unknown. The understanding of how
these neural components dictate immune functionmay prove to be essential in the under-
standing of diseases with increased autonomic activity, and thus provide novel avenues for
therapeutic intervention.
Supporting Information
S1 Fig. NE invokes a dose-dependentdecrease in T-lymphocyte proliferation. T-lympho-
cytes were isolated, purified, and activated via CD3/CD28 stimulation in the presence of
increasing amounts of NE.A. T-lymphocyte growth curves at various time points of ex vivo
culture. N = 4. B. Representative flow cytometry histogram demonstrating population shift of
NE-treated T-lymphocytes. p<0.05 vs. 0 μM NE by Student’s t-test at respective time points.
(TIF)
S2 Fig. NE increasesO2
- in all T-lymphocytes independent of activation stage. T-lympho-
cytes were isolated, purified, and activated via CD3/CD28 stimulation in the presence of 1 μM
NE.A. Representative gating strategy and flow cytometry histograms to assess DHE oxidation
in the various activation stages of T-lymphocytes at 96 hours with and without NE. N = Naïve,
CM = CentralMemory, E/M = Effector/EffectorMemory. B. Quantification of activation
stages in CD4+ (left) and CD8+ (right) T-lymphocytes activated in the presence of NE for 96
hours. N = 4. C. Quantification of DHE oxidation in various activation stages of CD4+ (left)
and CD8+ (right) T-lymphocytes activated in the presence of NE for 96 hours. N = 4. p<0.05
vs. 0 μM NE by 2-way ANOVA followed by Bonferroni post-hoc analysis.
(TIF)
S3 Fig. NE does not directly oxidize DHE.NE was incubated in T-lymphocyte culture media
in a cell free environment in the presence/absence of DHE for 30 minutes at 37°C. Quantifica-
tion of fluorescence by spectrophotometry at the end of the assay demonstrating NE does not
directly oxidize DHE in the absence of cells. N = 3. p<0.05 vs. -DHE by 2-way ANOVA fol-
lowed by Bonferroni post-hoc analysis.
(TIF)
S4 Fig. Atomoxetine (Atom) inhibits T-lymphocyte proliferation independent of exoge-
nous NE. T-lymphocytes were isolated, purified, and activated via CD3/CD28 stimulation in
the presence of increasing amounts of the NE transport inhibitor Atom. A. T-lymphocyte
growth curves at various time points of ex vivo culture. N = 5. B. T-lymphocyte growth curves
at various time points of ex vivo culture in combination with NE. N = 5. p<0.05 vs. 0 μM
Atom (vehicle) by Student’s t-test at respective time points.
(TIF)
S5 Fig. High doses of adrenergic antagonists inhibit CD4+ T-lymphocyte proliferation.
CD4+ T-lymphocytes were isolated, purified, and activated via CD3/CD28 stimulation in the
presence of increasing amounts of a respective adrenergic antagonist. T-lymphocyte growth
curves at various time points of ex vivo culture with increasing amounts of A. prazosin (Praz;
1), B. atipamezole (Atip; 2), C. metoprolol (Met; 1), orD. ICI 118,511 (ICI; 2). N = 4.
p<0.05 vs. 0 μM (vehicle) by Student’s t-test at respective time points.
(TIF)
S6 Fig. CD8+ T-lymphocytes show sensitivity to high dose adrenergic antagonists.CD8
+ T-lymphocytes were isolated, purified, and activated via CD3/CD28 stimulation in the pres-
ence of increasing amounts of a respective adrenergic antagonist. T-lymphocyte growth curves
at various time points of ex vivo culture with increasing amounts of A. prazosin (Praz; 1), B.
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atipamezole (Atip; 2), C. metoprolol (Met; 1), orD. ICI 118,511 (ICI; 2). N = 4. p<0.05 vs.
0 μM (vehicle) by Student’s t-test at respective time points.
(TIF)
S7 Fig. -blockade rescues fromNE-mediateddecreases in proliferation. T-lymphocytes
were isolated, purified, and activated via CD3/CD28 stimulation in the presence of 0 μM (vehi-
cle) or 1 μM NE with 1 μM of the respective adrenergic antagonist (or combination).A. Upper,
CD4+ T-lymphocyte growth curves at various time points of ex vivo culture with prazosin
(Praz; 1) and/or atipamezole (Atip; 2). Lower, CD4+ T-lymphocyte growth curves at various
time points of ex vivo culture with metoprolol (Met; 1) and/or ICI 118,511 (ICI; 2). B.
Upper, CD8+ T-lymphocyte growth curves at various time points of ex vivo culture with prazo-
sin (Praz; 1) and/or atipamezole (Atip; 2). Lower, CD8+ T-lymphocyte growth curves at var-
ious time points of ex vivo culture with metoprolol (Met; 1) and/or ICI 118,511 (ICI; 2).
N = 4. p<0.05 vs. 0 μM (vehicle), †p<0.05 vs. NE by Student’s t-test at respective time points.
(TIF)
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